Openbookopenbook
Equity
AZN
+0.0 · +0.00%
GBX · LSE

AstraZeneca PLC(AZN) Stock Analysis | Healthcare

GBX --+0.00%
Reward65Moderate
Risk21Low
75%Data
Strong 17% profit margin · 2.7% dividend yield
Quality Compounder
Market Cap:185.64Bn
ⓘ
Reward Rating
65
Moderate
Reward Assessment
75% data coverage
Top 50% of stocksView factors
ⓘ
Risk Rating
21
Low
Risk Assessment
1 metric flaggedView details

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

Educational tool only · More
Limited data coverage
We don't have enough public data on AZN to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
New listing — limited trading history
Fundamental and analyst data are available for AZN, but momentum and volatility metrics will develop as more trading history accumulates (0 trading sessions so far).
Not available yet for this stock
The ai tab requires data we don't have for this stock yet. The price chart is the most reliable view we have — try the Chart tab.
Openbook AIFour sections, four sub-agents

The current story

Narrative agent · what the company is, the industry around it, and what is still unsettled

Three to four paragraphs of prose, almost no numbers. Then up to six news links from the last month.

The bull case

Bull agent · the strongest honest version of the argument for owning it

Three to four labelled points. This is where the financials sit.

The bear case

Bear agent · reads the bull case and answers it point for point

The same shape as the bull case, written against it.

Key risks

Risk agent · what would have to go wrong, operationally and financially

Operational and financial risks, three to four labelled points.

openbook

Stock research for UK and US investors. Make smarter decisions, faster.

Questions? Email us at contact@openbookanalytics.com

© 2026 Openbook Analytics Ltd · Company No. SC843579 · Registered in Scotland

256-bit encryption GDPR compliant UK data centres

Openbook Analytics Ltd (Company No. SC843579) is registered in Scotland. Registered office: Strathclyde Inspire Hub, University of Strathclyde, Graham Hills Building (Level 6), 50 Richmond Street, Glasgow, G1 1XP. Openbook Analytics is not authorised or regulated by the Financial Conduct Authority (FCA). The content on this platform is provided for general informational and educational purposes only and does not constitute financial advice, investment advice, trading advice, or any other form of advice. You should not treat any content on this platform as a recommendation to buy, sell, or hold any financial instrument. Past performance is not a reliable indicator of future results. The value of investments and the income from them can go down as well as up, and you may get back less than you invest. User-generated content, including community posts and commentary, reflects the personal opinions of individual users, is not verified for accuracy, and does not represent the views of Openbook Analytics Ltd. You should always conduct your own research or consult a qualified, FCA-regulated financial adviser before making investment decisions. Data displayed on this platform may be delayed or inaccurate and is provided "as is" without warranty. Openbook Analytics Ltd accepts no liability for any loss arising from reliance on the information provided.